Tihomir Tomašič received his degree in pharmacy in 2006 and his PhD in pharmaceutical sciences in 2011 from the University of Ljubljana, Faculty of Pharmacy, Ljubljana, Slovenia. He conducted his post-doctoral research at Inte:Ligand, Vienna, Austria, under the supervision of Prof. Dr. Sharon D. Bryant. At present, he is an associate professor of medicinal chemistry at the Faculty of Pharmacy, University of Ljubljana. His main research interests concern computer-aided design, synthesis, and evaluation of biologically active compounds, particularly with anticancer and antibacterial activity. His research focus at present is on the development of ion channels and Hsp90 inhibitors with anticancer activity.